Discover
PVLA
Palvella Therapeutics, Inc.
138.77
2 x 111.17
2 x 195.41
bid
ask
+
7.43
5.66%
2 @ 04:00 PM
138.77 +0.00 (0.00%)
| Ytd | 32.58% | |
| 1y | 97.99% |
128.80
day range
139.81
69.90
52 week range
158.13
| Open | 130.70 | Prev Close | 131.34 | Low | 128.80 | High | 139.81 | Mkt Cap | 2.00B |
| Vol | 174.04K | Avg Vol | 211.36K | EPS | -5.12 | P/E | N/A | Forward P/E | -18.51 |
| Beta | -0.27 | Short Ratio | 11.81 | Inst. Own | 103.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 147.85 | 200-d Avg | 124.44 | 1yr Est | 230.53 |
| Income Statement | |||
| Operating Expenses | 21.41M | ||
| Research and Development Expense | 12.47M | ||
| Selling, General and Administrative Expense | 8.93M | ||
| Operating Income | -21.40M | ||
| Interest Expense | 2.31M | ||
| Net Income | -21.87M | ||
| Net Income Common Stock | -21.87M | ||
| Net Income Common Stock (USD) | -21.87M | ||
| Consolidated Income | -21.87M | ||
| Earnings per Basic Share | -1.52 | ||
| Earnings per Basic Share (USD) | -1.52 | ||
| Earnings per Diluted Share | -1.52 | ||
| Earning Before Interest & Taxes (EBIT) | -19.56M | ||
| Earning Before Interest & Taxes (USD) | -19.56M | ||
| Weighted Average Shares | 14.36M | ||
| Weighted Average Shares Diluted | 14.36M | ||
| Balance Sheet | |||
| Cash and Equivalents | 187.80M | ||
| Cash and Equivalents (USD) | 187.80M | ||
| Investments | 62.78M | ||
| Investments Current | 62.78M | ||
| Current Assets | 253.03M | ||
| Property, Plant & Equipment Net | 482.00K | ||
| Total Assets | 253.51M | ||
| Debt Current | 217.00K | ||
| Total Debt | 535.00K | ||
| Current Liabilities | 11.95M | ||
| Debt Non-Current | 318.00K | ||
| Total Liabilities | 36.64M | ||
| Accumulated Retained Earnings (Deficit) | -173.09M | ||
| Accumulated Other Comprehensive Income | 89.00K | ||
| Shareholders Equity | 216.87M | ||
| Shareholders Equity (USD) | 216.87M | ||
| Assets Non-Current | 482.00K | ||
| Total Debt (USD) | 535.00K | ||
| Liabilities Non-Current | 24.70M | ||
| Trade and Non-Trade Payables | 6.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 45.00K | ||
| Net Cash Flow from Financing | 1.28M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -18.59M | ||
| Issuance (Purchase) of Equity Shares | 1.28M | ||
| Net Cash Flow from Investing | -7.03M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -7.03M | ||
| Net Cash Flow from Operations | -12.84M | ||
| Effect of Exchange Rate Changes on Cash | 6.00K | ||
| Share Based Compensation | 5.16M | ||